Global Upper Respiratory Tract Infection Treatment Market 2024-2028

The upper respiratory tract infection treatment market is forecasted to grow by USD 2,661.15 mn during 2023-2028, accelerating at a CAGR of 4.21% during the forecast period. The report on the upper respiratory tract infection treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence and prevalence of upper respiratory tract infections, favorable drug pipeline, and rising demand for over-the-counter drugs.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	3.46%
CAGR	4.21%
Incremental Value	$2661.15mn

Technavio's upper respiratory tract infection treatment market is segmented as below:

By Type

Antibiotics
NSAIDs and nasal decongestants
Others

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emergence of biologics as one of the prime reasons driving the upper respiratory tract infection treatment market growth during the next few years. Also, development of drug delivery devices to treat upper respiratory tract infections and technological advancements in treatment options will lead to sizable demand in the market.

The report on the upper respiratory tract infection treatment market covers the following areas:

Upper respiratory tract infection treatment market sizing
Upper respiratory tract infection treatment market forecast
Upper respiratory tract infection treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading upper respiratory tract infection treatment market vendors that include AstraZeneca Plc, CSL Ltd., GlaxoSmithKline Plc, MD Total Care LLC., Medtronic Plc, Merck and Co. Inc., Novartis AG, Parkway Holdings Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi, Teva Pharmaceutical Industries Ltd., The Cleveland Clinic Foundation, and Yashoda Hospitals. Also, the upper respiratory tract infection treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43396

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global upper respiratory tract infection treatment market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global upper respiratory tract infection treatment market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Antibiotics - Market size and forecast 2023-2028
Exhibit 34: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
6.4 NSAIDs and nasal decongestants - Market size and forecast 2023-2028
Exhibit 38: Chart on NSAIDs and nasal decongestants - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on NSAIDs and nasal decongestants - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on NSAIDs and nasal decongestants - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on NSAIDs and nasal decongestants - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ million)
Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 50: Chart on Comparison by Distribution Channel
Exhibit 51: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 52: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 60: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ million)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AstraZeneca Plc
Exhibit 115: AstraZeneca Plc - Overview
Exhibit 116: AstraZeneca Plc - Product / Service
Exhibit 117: AstraZeneca Plc - Key news
Exhibit 118: AstraZeneca Plc - Key offerings
12.4 CSL Ltd.
Exhibit 119: CSL Ltd. - Overview
Exhibit 120: CSL Ltd. - Business segments
Exhibit 121: CSL Ltd. - Key offerings
Exhibit 122: CSL Ltd. - Segment focus
12.5 GlaxoSmithKline Plc
Exhibit 123: GlaxoSmithKline Plc - Overview
Exhibit 124: GlaxoSmithKline Plc - Business segments
Exhibit 125: GlaxoSmithKline Plc - Key news
Exhibit 126: GlaxoSmithKline Plc - Key offerings
Exhibit 127: GlaxoSmithKline Plc - Segment focus
12.6 MD Total Care LLC.
Exhibit 128: MD Total Care LLC. - Overview
Exhibit 129: MD Total Care LLC. - Product / Service
Exhibit 130: MD Total Care LLC. - Key offerings
12.7 Medtronic Plc
Exhibit 131: Medtronic Plc - Overview
Exhibit 132: Medtronic Plc - Business segments
Exhibit 133: Medtronic Plc - Key news
Exhibit 134: Medtronic Plc - Key offerings
Exhibit 135: Medtronic Plc - Segment focus
12.8 Merck and Co. Inc.
Exhibit 136: Merck and Co. Inc. - Overview
Exhibit 137: Merck and Co. Inc. - Business segments
Exhibit 138: Merck and Co. Inc. - Key news
Exhibit 139: Merck and Co. Inc. - Key offerings
Exhibit 140: Merck and Co. Inc. - Segment focus
12.9 Novartis AG
Exhibit 141: Novartis AG - Overview
Exhibit 142: Novartis AG - Business segments
Exhibit 143: Novartis AG - Key offerings
Exhibit 144: Novartis AG - Segment focus
12.10 Parkway Holdings Ltd.
Exhibit 145: Parkway Holdings Ltd. - Overview
Exhibit 146: Parkway Holdings Ltd. - Product / Service
Exhibit 147: Parkway Holdings Ltd. - Key offerings
12.11 Pfizer Inc.
Exhibit 148: Pfizer Inc. - Overview
Exhibit 149: Pfizer Inc. - Product / Service
Exhibit 150: Pfizer Inc. - Key news
Exhibit 151: Pfizer Inc. - Key offerings
12.12 Regeneron Pharmaceuticals Inc.
Exhibit 152: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 153: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 154: Regeneron Pharmaceuticals Inc. - Key offerings
12.13 Sanofi
Exhibit 155: Sanofi - Overview
Exhibit 156: Sanofi - Business segments
Exhibit 157: Sanofi - Key news
Exhibit 158: Sanofi - Key offerings
Exhibit 159: Sanofi - Segment focus
12.14 Teva Pharmaceutical Industries Ltd.
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
12.15 The Cleveland Clinic Foundation
Exhibit 165: The Cleveland Clinic Foundation - Overview
Exhibit 166: The Cleveland Clinic Foundation - Product / Service
Exhibit 167: The Cleveland Clinic Foundation - Key offerings
12.16 Yashoda Hospitals
Exhibit 168: Yashoda Hospitals - Overview
Exhibit 169: Yashoda Hospitals - Product / Service
Exhibit 170: Yashoda Hospitals - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations